
Keywords: Organ donation; Biomarker; Clinical trial; Transplantation; Risk prediction; Brain death; IL-6; interleukin-6; SLPI; secretory leukocyte protease inhibitor; IDI; integrated discrimination improvement; DND; donation after neurologic death; MOnIToR; Monitor